IRBESARTAN

Product NDC
50090-3269
11-digit product format
500903269
Labeler code
50090
Product ID
50090-3269_32265c04-5b29-40e1-9cc7-218ea79b393c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
IRBESARTAN
Dosage form
TABLET
Route
ORAL
Labeler
A-S Medication Solutions
Application
ANDA203534
Marketing category
ANDA
Marketing start
2015-02-24
Marketing end
0000-00-00
Substance
IRBESARTAN
Active strength
300 mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50090-3269-0EA - Each50090-32697903e2db-a9c0-4389-870c-ab708093c13512019-05-02
50090-3269-1EA - Each50090-3269737db3d3-95bc-47e5-8860-f73517f8c04e12021-09-07
50090-3269-2EA - Each50090-32692842898e-c11f-4da8-b370-ef86c7c13d6c12019-05-02

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
50090-3269-05009032690030 TABLET in 1 BOTTLE (50090-3269-0) 30 tablet2017-11-170000-00-00NoNoCurrent
50090-3269-15009032690190 TABLET in 1 BOTTLE, PLASTIC (50090-3269-1) 90 tablet2015-02-240000-00-00NoNoCurrent
50090-3269-25009032690290 TABLET in 1 BOTTLE (50090-3269-2) 90 tablet2018-03-150000-00-00NoNoCurrent